Anjali Pawar
Pediatric Hematology-Oncology · Sacramento, CANPI 1851425060
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $24,409 of the $27,874 with a category attached, or 87.6%. Genentech USA, Inc. accounts for 70.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $10,797 and has fallen 99.9% since, to $14 in 2025.
Across 30 payments — averaging $929.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$20K
- Bayer$4K
- Sobi, Inc$3K
- Novartis$1K
- Shire North American Group Inc$155
- Spark Therapeutics, Inc.$100
- plus $32 from 2 others
Across 119 payments — averaging $9884.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$869K
- Pfizer$105K
- Boehringer Ingelheim$87K
- Octapharma USA, Inc.$56K
- Dova Pharmaceuticals$29K
- Sobi, Inc$28K
- plus $2K from 1 others
What the payments were for
- Consulting fees$24,40988%
- Travel & lodging$2,1858%
- Food & beverage$1,2815%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 17 | $19,760 |
| Bayer | 6 | $3,599 |
| Sobi, Inc | 1 | $2,775 |
| Novartis | 2 | $1,453 |
| Shire North American Group Inc | 1 | $155 |
| Spark Therapeutics, Inc. | 1 | $100 |
| Novo Nordisk | 1 | $18 |
| Agios Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,874 in reported general payments places this provider in the 85th percentile of 307 pediatric hematology-oncology providers in California.
See all pediatric hematology-oncology providers in California →
Other pediatric hematology-oncology in Sacramento
- Arun PanigrahiSacramento$103K
- Jonathan DucoreSacramento$23K
- Philip PizzoPalo Alto$2.6M
- Vinod BalasaMadera$508K
- Akshat JainRedlands$447K
- Noah FedermanLos Angeles$399K
- Vanessa Salinas-LunaOrange$344K
- Daniel KraftStanford$294K
- Arash MahajerinOrange$249K
- Elysia AlvarezPalo Alto$200K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.